Clinical Trials Browser

Phase 3 × Has announcements × Erlotinib Hydrochloride × Clear all

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung